Known For
Recent Appearances
✨
Biologic selection is less critical than initiating systemic therapy for uncontrolled atopic dermatitis.
✨
Zasocitinib showed high skin clearance in phase 3 trials.
✨
FDA accepted NDA for zasocitinib for plaque psoriasis.